跳至主要内容
临床试验/ACTRN12624001166561
ACTRN12624001166561招募中Unknown

Metabolomic Profiling and Cardiovascular Outcomes in Patients with Cirrhotic Cardiomyopathy Undergoing Liver Transplantation

Dr Madeleine Gill0 个研究点目标入组 150 人开始时间: 2024年9月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patients undergoing assessment for liver transplantation at the Australian National Liver Transplant Unit at The Royal Prince Alfred Hospital will be prospectively recruited

排除标准

  • Patients with non-cirrhotic indications for liver transplant 2) Patients undergoing multi-organ transplantation 3) Patients with haemodynamically significant valvular heart disease, non-revascularised coronary artery disease, or any pre-existing non-cirrhotic cardiomyopathy 4) Patients with underlying liver diseases that can potentially cause infilitrative cardiovascular disease such as amyloidosis, sarcodosis, or haemochromotosis

研究者

发起方
Dr Madeleine Gill

相似试验